Skip to main content

DESCIFRANDO LAS INTERACCIONES ENTRE LA MICROBIOTA INTESTINAL / VIRUS ENTERICOS / HOSPEDADOR: BASES PARA PROTEGER FRENTE A LA DIARREA VIRICA

AGL2017-84165-C2-2-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSITAT DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Epidemiological Surveillance of Norovirus and Rotavirus in Sewage (2016–2017) in Valencia (Spain)

  • Santiso-Bellón, Cristina
  • Randazzo, Walter
  • Pérez-Cataluña, Alba
  • Vila-Vicent, Susana
  • Gozalbo-Rovira, Roberto
  • Muñoz, Carlos
  • Buesa, Javier
  • Sánchez Moragas, Gloria
  • Rodríguez Díaz, Jesús
© 2020 by the authors., The aim of the present study was to perform the molecular epidemiology of rotaviruses and noroviruses detected in sewage samples from a large wastewater facility from the city of Valencia, Spain. A total of 46 sewage samples were collected over a one-year period (September 2016 to September 2017). Norovirus and rotavirus were detected and quantified by RT-qPCR, genotyped by semi-nested RT-PCR and further characterized by sequencing and phylogenetic analyses. Noroviruses and rotaviruses were widely distributed in sewage samples (69.6% for norovirus GI, 76.0% norovirus GII, and 71.7% rotaviruses) and viral loads varied from 4.33 to 5.75 log PCRU/L for norovirus GI, 4.69 to 6.95 log PCRU/L for norovirus GII, and 4.08 to 6.92 log PCRU/L for rotavirus. Overall, 87.5% (28/32) of GI noroviruses could not be genotyped, 6.25% (2/32) of the samples contained GI.2 genotype, and another 6.25% (2/32) were positive for GI.4 genotype. The most common genotype of GII noroviruses was GII.2 (40%, 14/35), followed by GII.6 (8.6%, 3/35) and GII.17 (5.7%, 2/35) while the remaining GII strains could not be typed (45.7%, 16/35). Rotavirus VP4 genotype P[8] was the only one found in 19 out of 33 rotavirus-positive samples (57.7%). G2 was the most prevalent rotavirus VP7 genotype (15.2%, 5/33) followed by G3, G9, and G12, with two positive samples for each genotype (6.1%, 2/33). In one sample both G1 and G2 genotypes were detected simultaneously (3%). The results presented here show that the surveillance of noroviruses and rotaviruses in sewage is useful for the study of their transmission in the population and their molecular epidemiology., This work was supported by Spanish Government (Ministerio de Economía y Competitividad) grants AGL2017-84165-C2-2-R, RYC-2013-12442, and AGL2017-82909-R (AEI/FEDER, UE) funded by Spanish Ministry of Science, Innovation and Universities. This work was also founded by the Generalitat Valenciana and the UE FEDER program IDIFER/2018/056. CSB is the recipient of a predoctoral grant FPI from the Spanish Government RE2018-083315. RGR and WR are supported by postdoctoral fellowships from Valencian Government (APOST/2017/037 and APOSTD/2018/150)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Human milk and mucosa-associated disaccharides impact on cultured infant fecal microbiota

  • Rubio del Campo, Antonio
  • Alcántara, Cristina
  • Collado, María Carmen
  • Rodríguez-Díaz, Jesús
  • Yebra, María Jesús
Human milk oligosaccharides (HMOs) are a mixture of structurally diverse carbohydrates that contribute to shape a healthy gut microbiota composition. The great diversity of the HMOs structures does not allow the attribution of specific prebiotic characteristics to single milk oligosaccharides. We analyze here the utilization of four disaccharides, lacto-N-biose (LNB), galacto-N-biose (GNB), fucosyl-α1,3-GlcNAc (3FN) and fucosyl-α1,6-GlcNAc (6FN), that form part of HMOs and glycoprotein structures, by the infant fecal microbiota. LNB significantly increased the total levels of bifidobacteria and the species Bifidobacterium breve and Bifidobacterium bifidum. The Lactobacillus genus levels were increased by 3FN fermentation and B. breve by GNB and 3FN. There was a significant reduction of Blautia coccoides group with LNB and 3FN. In addition, 6FN significantly reduced the levels of Enterobacteriaceae family members. Significantly higher concentrations of lactate, formate and acetate were produced in cultures containing either LNB or GNB in comparison with control cultures. Additionally, after fermentation of the oligosaccharides by the fecal microbiota, several Bifidobacterium strains were isolated and identified. The results presented here indicated that each, LNB, GNB and 3FN disaccharide, might have a specific beneficial effect in the infant gut microbiota and they are potential prebiotics for application in infant foods., This work was supported by the Spanish Ministry for Economy and Competitiveness (MINECO)/FEDER through the Project AGL2017-84165-C2 (1-R and 2-R). M.C.C. would like to acknowledge the support from European Research Council under the European Union's Horizon 2020 research and innovation programme (ERC starting grant, n° 639226), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Interaction of Intestinal Bacteria with Human Rotavirus during Infection in Children

  • Gozalbo-Rovira, Roberto
  • Rubio del Campo, Antonio
  • Santiso-Bellón, Cristina
  • Vila-Vicent, Susana
  • Buesa, Javier
  • Delgado, Susana
  • Molinero, Natalia
  • Margolles Barros, Abelardo
  • Yebra, María Jesús
  • Collado, María Carmen
  • Monedero, Vicente
  • Rodríguez-Díaz, Jesús
The gut microbiota has emerged as a key factor in the pathogenesis of intestinal viruses, including enteroviruses, noroviruses and rotaviruses (RVs), where stimulatory and inhibitory effects on infectivity have been reported. With the aim of determining whether members of the microbiota interact with RVs during infection, a combination of anti-RV antibody labeling, fluorescence-activated cell sorting and 16S rRNA amplicon sequencing was used to characterize the interaction between specific bacteria and RV in stool samples of children suffering from diarrhea produced by G1P[8] RV. The genera <i>Ruminococcus</i> and <i>Oxalobacter</i> were identified as RV binders in stools, displaying enrichments between 4.8- and 5.4-fold compared to samples nonlabeled with anti-RV antibodies. In vitro binding of the G1P[8] Wa human RV strain to two <i>Ruminococcus gauvreauii</i> human isolates was confirmed by fluorescence microscopy. Analysis in <i>R. gauvreauii</i> with antibodies directed to several histo-blood group antigens (HBGAs) indicated that these bacteria express HBGA-like substances on their surfaces, which can be the target for RV binding. Furthermore, in vitro infection of the Wa strain in differentiated Caco-2 cells was significantly reduced by incubation with <i>R. gauvreauii.</i> These data, together with previous findings showing a negative correlation between <i>Ruminococcus</i> levels and antibody titers to RV in healthy individuals, suggest a pivotal interaction between this bacterial group and human RV. These results reveal likely mechanisms of how specific bacterial taxa of the intestinal microbiota could negatively affect RV infection and open new possibilities for antiviral strategies., This research was supported by Spanish Government (Ministerio de Economía y Competitividad) grants AGL2017-84165-C2-1-R to M.J.Y. and AGL2017-84165-C2-2-R and RYC-2013-12442 to J.R.-D. This work was also supported by Valencian Government grant IDIFEDER/2018/056. R.G.-R. is the recipient of a postdoctoral grant from the Valencian Government APOST/2017/037. C.S.-B. is the recipient of a predoctoral grant FPI from the Spanish Government RE2018-083315. S.V.-V. is the recipient of a predoctoral grant from the Valencian Government ACIF/2016/437., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Microbiota Depletion Promotes Human Rotavirus Replication in an Adult Mouse Model

  • Gozalbo-Rovira, Roberto
  • Santiso Bellón, Cristina
  • Buesa, Javier
  • Rubio del Campo, Antonio
  • Vila Vicent, Susana
  • Muñoz, Carlos
  • Yebra, María Jesús
  • Monedero, Vicente
  • Rodríguez-Díaz, Jesús
Intestinal microbiota-virus-host interaction has emerged as a key factor in mediating enteric virus pathogenicity. With the aim of analyzing whether human gut bacteria improve the inefficient replication of human rotavirus in mice, we performed fecal microbiota transplant (FMT) with healthy infants as donors in antibiotic-treated mice. We showed that a simple antibiotic treatment, irrespective of FMT, resulted in viral shedding for 6 days after challenge with the human rotavirus G1P[8] genotype Wa strain (RVwa). Rotavirus titers in feces were also significantly higher in antibiotic-treated animals with or without FMT but they were decreased in animals subject to self-FMT, where a partial re-establishment of specific bacterial taxons was evidenced. Microbial composition analysis revealed profound changes in the intestinal microbiota of antibiotic-treated animals, whereas some bacterial groups, including members of Lactobacillus, Bilophila, Mucispirillum, and Oscillospira, recovered after self-FMT. In antibiotic-treated and FMT animals where the virus replicated more efficiently, differences were observed in gene expression of immune mediators, such as IL1β and CXCL15, as well as in the fucosyltransferase FUT2, responsible for H-type antigen synthesis in the small intestine. Collectively, our results suggest that antibiotic-induced microbiota depletion eradicates the microbial taxa that restrict human rotavirus infectivity in mice., This research was funded by Spanish Government (Ministerio de Economía y Competitividad) grants AGL2017-84165-C2-1-R to MJY, AGL2017-84165-C2-2-R to JRD. The study was also supported by Valencian Government grant IDIFEDER/2018/056 and by European FEDER founds. RGR is the recipient of a postdoctoral grant from the Valencian Government (APOST/2017/037). CSB is the recipient of a FPI predoctoral grant from the Spanish Government (RE2018-083315). SVV is the recipient of a predoctoral grant from the Valencian Government (ACIF/2016/437)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Infant-gut associated Bifidobacterium dentium strains utilize the galactose moiety and release lacto-N-triose from the human milk oligosaccharides lacto-N-tetraose and lacto-N-neotetraose

  • Moya Gonzálvez, Eva M.
  • Rubio del Campo, Antonio
  • Rodríguez-Díaz, Jesús
  • Yebra, María Jesús
Much evidence suggests a role for human milk oligosaccharides (HMOs) in establishing the infant microbiota in the large intestine, but the response of particular bacteria to individual HMOs is not well known. Here twelve bacterial strains belonging to the genera Bifidobacterium, Enterococcus, Limosilactobacillus, Lactobacillus, Lacticaseibacillus, Staphylococcus and Streptococcus were isolated from infant faeces and their growth was analyzed in the presence of the major HMOs, 2'-fucosyllactose (2'FL), 3-fucosyllactose (3FL), 2',3-difucosyllactose (DFL), lacto-N-tetraose (LNT) and lacto-N-neo-tetraose (LNnT), present in human milk. Only the isolated Bifidobacterium strains demonstrated the capability to utilize these HMOs as carbon sources. Bifidobacterium infantis Y538 efficiently consumed all tested HMOs. Contrarily, Bifidobacterium dentium strains Y510 and Y521 just metabolized LNT and LNnT. Both tetra-saccharides are hydrolyzed into galactose and lacto-N-triose (LNTII) by B. dentium. Interestingly, this species consumed only the galactose moiety during growth on LNT or LNnT, and excreted the LNTII moiety. Two β-galactosidases were characterized from B. dentium Y510, Bdg42A showed the highest activity towards LNT, hydrolyzing it into galactose and LNTII, and Bdg2A towards lactose, degrading efficiently also 6'-galactopyranosyl-N-acetylglucosamine, N-acetyl-lactosamine and LNnT. The work presented here supports the hypothesis that HMOs are mainly metabolized by Bifidobacterium species in the infant gut., This work is part of the Grants AGL2017-84165-C2 (1-R and 2-R) and PID2020-115403RB (C21 and C22) funded by the Spanish Ministry of Science and Innovation (MICIN)/Spanish State Research Agency (AEI)/10.13039/501100011033, and by "ERDF A way of making Europe"., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The Role of Host Glycobiology and Gut Microbiota in Rotavirus and Norovirus Infection, an Update

  • Peña Gil, Nazaret
  • Santiso Bellón, Cristina
  • Gozalbo-Rovira, Roberto
  • Buesa, Javier
  • Monedero, Vicente
  • Rodríguez-Díaz, Jesús
Rotavirus (RV) and norovirus (NoV) are the leading causes of acute gastroenteritis (AGE) worldwide. Several studies have demonstrated that histo-blood group antigens (HBGAs) have a role in NoV and RV infections since their presence on the gut epithelial surfaces is essential for the susceptibility to many NoV and RV genotypes. Polymorphisms in genes that code for enzymes required for HBGAs synthesis lead to secretor or non-secretor and Lewis positive or Lewis negative individuals. While secretor individuals appear to be more susceptible to RV infections, regarding NoVs infections, there are too many discrepancies that prevent the ability to draw conclusions. A second factor that influences enteric viral infections is the gut microbiota of the host. In vitro and animal studies have determined that the gut microbiota limits, but in some cases enhances enteric viral infection. The ways that microbiota can enhance NoV or RV infection include virion stabilization and promotion of virus attachment to host cells, whereas experiments with microbiota-depleted and germ-free animals point to immunoregulation as the mechanism by which the microbiota restrict infection. Human trials with live, attenuated RV vaccines and analysis of the microbiota in responder and non-responder individuals also allowed the identification of bacterial taxa linked to vaccine efficacy. As more information is gained on the complex relationships that are established between the host (glycobiology and immune system), the gut microbiota and intestinal viruses, new avenues will open for the development of novel anti-NoV and anti-RV therapies., This research was supported by Spanish Ministry of Science and Innovation (MICIN)/Spanish State Research Agency (AEI)/10.13039/ 501100011033, and by “ERDF A way of making Europe” grants AGL2017-84165-C2-2-R and PID2020-115403RB-C22 to J.R.-D., C.S.-B. is the recipient of a predoctoral grant RE2018-083315 funded by MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future”. This work was also supported by Valencian Government grant IDIFEDER/2018/056. N.P.-G. is the recipient of a predoctoral grant from the Valencian Government ACIF/2020/085. R.G.-R. is the recipient of a postdoctoral grant from the Valencian Government APOST/2017/037., Peer reviewed